Psychological Factors Influencing Cancer Post-traumatic Growth
Launched by CENTRE HOSPITALIER DE VALENCIENNES · Feb 22, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain psychological factors can influence positive changes in cancer patients after they experience trauma related to their illness. Specifically, the researchers want to understand if emotional skills, the ability to adapt to change, and how satisfied patients feel with their care at the beginning of treatment can affect their personal growth after completing chemotherapy. The study will look at patients with different types of solid tumors to see how these factors play a role over time.
To be eligible for this study, participants must be adults over 18 years old who are starting their first round of curative treatment for a solid cancer, and they should be within six months of their initial diagnosis. Patients who have had cancer before or whose cancer has advanced or returned are not eligible. If you join the study, you will complete questionnaires at the start of your treatment and again after finishing chemotherapy, as well as at the six-month mark, to help researchers learn more about the connection between psychological factors and personal growth in cancer survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 18 years of age
- • Patients in the initial phase of curative treatment for a 1st solid cancer
- • At the start of neo-adjuvant or adjuvant chemotherapy (1st course or 2nd course)
- • At less than 6 months from the initial diagnosis
- • Patient having given written consent to participate in the study
- Exclusion Criteria:
- • Patients with a previous history of cancer
- • Patients with incurable cancer progression, recurrence or relapse
- • Metastatic, brain, hematological or skin cancer
- • Patients who have difficulty understanding written French
- • Patient psychologically or physically unable to answer questionnaires
About Centre Hospitalier De Valenciennes
The Centre Hospitalier de Valenciennes is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Valenciennes, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge scientific inquiry. With a multidisciplinary team of healthcare professionals and researchers, the Centre Hospitalier de Valenciennes aims to contribute to the development of new therapies and treatment strategies, enhancing the health outcomes of diverse patient populations. The institution adheres to rigorous ethical standards and regulatory guidelines, ensuring the highest quality and safety in its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valenciennes, , France
Patients applied
Trial Officials
Anne-Sophie Baudry
Principal Investigator
CH de Valenciennes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported